● Recruiting

Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer

Condition: Endometrial Cancer · Sponsor: Faeth Therapeutics

PhasePhase 2

Planned participants40

Who can joinFemale, 18 Years to no upper limit

Healthy volunteersNo

About this study

This is a Phase 2, multicenter, open-label, single-arm study to evaluate the efficacy and safety of sapanisertib and serabelisib (PIKTOR) with paclitaxel in participants with advanced or recurrent endometrial cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Medical Monitor · (708)406-9282 · clinicaltrials@faeththerapeutics.com

Always discuss trial participation with your own doctor first.

Locations (18)

UC San Diego Moores Cancer Center	La Jolla, California, United States	Recruiting
University of California, San Francisco (UCSF)	San Francisco, California, United States	Recruiting
Mount Sinai Comprehensive Cancer Center	Miami Beach, Florida, United States	Recruiting
Florida Cancer Specialists, North	St. Petersburg, Florida, United States	Recruiting
Florida Cancer Specialists, East	West Palm Beach, Florida, United States	Recruiting
Maryland Oncology Hematology, P.A.	Brandywine, Maryland, United States	Recruiting
Minnesota Oncology Hematology, P.A.	Maple Grove, Minnesota, United States	Recruiting
Women's Cancer Care Associates, LLC	Albany, New York, United States	Recruiting
Memorial Sloan Kettering Cancer Center	New York, New York, United States	Recruiting
University of Cincinnati Medical Center	Cincinnati, Ohio, United States	Recruiting
Oncology Associates of Oregon, P.C.	Eugene, Oregon, United States	Recruiting
Northwest Cancer Specialists, P.C.	Portland, Oregon, United States	Recruiting

+ 6 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06463028